These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 28828194)

  • 1. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.
    Lin DM; Koskella B; Lin HC
    World J Gastrointest Pharmacol Ther; 2017 Aug; 8(3):162-173. PubMed ID: 28828194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections.
    Taati Moghadam M; Amirmozafari N; Shariati A; Hallajzadeh M; Mirkalantari S; Khoshbayan A; Masjedian Jazi F
    Infect Drug Resist; 2020; 13():45-61. PubMed ID: 32021319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable Phage-Loaded Microparticles Effectively Release Phages to Kill Methicillin-Resistant
    Xu Y; Yang T; Miao Y; Zhang Q; Yang M; Mao C
    ACS Appl Mater Interfaces; 2024 Apr; 16(14):17232-17241. PubMed ID: 38554078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Host Range Expansion of Therapeutic Bacteriophage Sb-1 with Allele State at a Hypervariable Repeat Locus.
    Sergueev KV; Filippov AA; Farlow J; Su W; Kvachadze L; Balarjishvili N; Kutateladze M; Nikolich MP
    Appl Environ Microbiol; 2019 Nov; 85(22):. PubMed ID: 31492663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Basis for Lytic Bacteriophage Resistance in Enterococci.
    Duerkop BA; Huo W; Bhardwaj P; Palmer KL; Hooper LV
    mBio; 2016 Aug; 7(4):. PubMed ID: 27578757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients.
    Zhang G; Zhao Y; Paramasivan S; Richter K; Morales S; Wormald PJ; Vreugde S
    Int Forum Allergy Rhinol; 2018 Mar; 8(3):406-414. PubMed ID: 29240296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of therapeutic phage cocktail and endolysin to highly multi-drug resistant
    Jasim HN; Hafidh RR; Abdulamir AS
    Iran J Basic Med Sci; 2018 Nov; 21(11):1100-1108. PubMed ID: 30483382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of a novel lytic bacteriophage obtained from clinical MRSA isolates and evaluation of its antibacterial activity].
    Sahin F; Karasartova D; Ozsan TM; Gerçeker D; Kıyan M
    Mikrobiyol Bul; 2013 Jan; 47(1):27-34. PubMed ID: 23390900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
    Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and Exploiting Phage-Host Interactions.
    Stone E; Campbell K; Grant I; McAuliffe O
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31216787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments.
    Johri AV; Johri P; Hoyle N; Pipia L; Nadareishvili L; Nizharadze D
    Front Pharmacol; 2021; 12():692614. PubMed ID: 34177601
    [No Abstract]   [Full Text] [Related]  

  • 15. A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against
    Wu M; Hu K; Xie Y; Liu Y; Mu D; Guo H; Zhang Z; Zhang Y; Chang D; Shi Y
    Front Microbiol; 2018; 9():3302. PubMed ID: 30687281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating bacterial infections with bacteriophages in the 21st century.
    Opperman CJ; Wojno JM; Brink AJ
    S Afr J Infect Dis; 2022; 37(1):346. PubMed ID: 35399556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial Activity of a Lytic Enzyme Encoded by
    Yang Y; Le S; Shen W; Chen Q; Huang Y; Lu S; Tan Y; Li M; Hu F; Li Y
    Front Microbiol; 2018; 9():1778. PubMed ID: 30127777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria.
    Hasan M; Ahn J
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.